Diagnostic anti-Luteinizing hormone (LH) antibodies (anti-Luteinizing hormone, anti-LH) and diagnostic hapten-carrier conjugates BSA-Luteinizing hormone (LH), OVA-Luteinizing hormone (LH), KLH-Luteinizing hormone (LH) antigens for Hormone disorders LH detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Genemedi produces core diagnostic ingredients for test of Hormone disorders (fertility) and related syndrome. GeneMedi offers paired anti-Luteinizing hormone (LH) antibodies (monoclonal antibody, mab) and Luteinizing hormone (LH antigens (Carrier-coupled antigen, immunogen, hapten-carrier conjugates, BSA-conjugated, OVA-conjugated, KLH-conjugated) for Hormone disorders (fertility) rapid test kit of Luteinizing hormone (LH) testing in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. The carrier-coupled antigens of small molecules can act as immunogens.In both males and females, Luteinizing hormone (LH) is essential for reproduction. In females, the menstrual cycle is divided by a midcycle surge of both LH and follicle-stimulating hormone (FSH) into a follicular phase and a luteal phase. This “LH surge” triggers ovulation thereby not only releasing the egg, but also initiating the conversion of the residual follicle into a corpus luteum that, in turn, produces progesterone to prepare the endometrium for a possible implantation. LH is necessary to maintain luteal function for the first 2 weeks. In case of pregnancy, luteal function will be further maintained by the action of human chorionic gonadotropin from the newly established pregnancy. LH supports thecal cells in the ovary that provide androgens and hormonal precursors for estradiol production. LH in males acts on testicular interstitial cells of Leydig to cause increased synthesis of testosterone.